P Mitchell1, J Jakubowski. 1. Department of Neurosurgery, Royal Hallamshire Hospital, Sheffield S10 2JF, UK. P.Mitchell@sheffield.ac.uk
Abstract
OBJECTIVES: To calculate the expected number of life-years saved by surgical treatment of unruptured intracranial aneurysms at ages over 20 years. METHODS: An actuarial risk analysis of the treatment of unruptured intracranial aneurysms based on data from the International Study of Unruptured Intracranial Aneurysms (ISUIA). The benefits of operative treatment are calculated in terms of average life-years saved. RESULTS: Results are presented as graphs of life-years saved or lost against age at the time of operative treatment for three groups of aneurysms: those under 10 mm in diameter with no history of subarachnoid haemorrhage (SAH) from another aneurysm, those under 10 mm in diameter and a history of previous SAH from a different aneurysm, and those over 10 mm in diameter. Life-years are lost at all ages in the group under 10 mm with no history of SAH. For the group under 10 mm with a history of SAH about 4 years are saved at age 20 declining to 0 at around age 50. For aneurysms 10 mm or more in diameter about 8 life-years are saved at age 20 declining to 0 at around 50. CONCLUSIONS: Clipping of unruptured aneurysms under 10 mm in diameter with no history of subarachnoid haemorrhage is not justified on actuarial grounds. Intervention in other unruptured aneurysms produces benefits in life expectancy up to the age of 50. There may be subgroups of aneurysms in which larger benefits exist.
OBJECTIVES: To calculate the expected number of life-years saved by surgical treatment of unruptured intracranial aneurysms at ages over 20 years. METHODS: An actuarial risk analysis of the treatment of unruptured intracranial aneurysms based on data from the International Study of Unruptured Intracranial Aneurysms (ISUIA). The benefits of operative treatment are calculated in terms of average life-years saved. RESULTS: Results are presented as graphs of life-years saved or lost against age at the time of operative treatment for three groups of aneurysms: those under 10 mm in diameter with no history of subarachnoid haemorrhage (SAH) from another aneurysm, those under 10 mm in diameter and a history of previous SAH from a different aneurysm, and those over 10 mm in diameter. Life-years are lost at all ages in the group under 10 mm with no history of SAH. For the group under 10 mm with a history of SAH about 4 years are saved at age 20 declining to 0 at around age 50. For aneurysms 10 mm or more in diameter about 8 life-years are saved at age 20 declining to 0 at around 50. CONCLUSIONS: Clipping of unruptured aneurysms under 10 mm in diameter with no history of subarachnoid haemorrhage is not justified on actuarial grounds. Intervention in other unruptured aneurysms produces benefits in life expectancy up to the age of 50. There may be subgroups of aneurysms in which larger benefits exist.
Authors: B Ljunggren; H Fodstad; C von Essen; H Säveland; L Brandt; J Hillman; B Romner; G Algers Journal: Br J Neurosurg Date: 1988 Impact factor: 1.596
Authors: H W ter Berg; D W Dippel; J D Habbema; J B Bijlsma; J van Gijn; C A Tulleken; J Willemse Journal: Neurosurgery Date: 1988-09 Impact factor: 4.654
Authors: Ahmad Sweid; Kareem El Naamani; Rawad Abbas; Robert M Starke; Khodr Badih; Rayan El Hajjar; Hassan Saad; Bassel Hammoud; Carrie Andrews; Sage P Rahm; Elias Atallah; Sunidhi Ramesh; Stavropoula Tjoumakaris; M Reid Gooch; Nabeel Herial; David Hasan; Robert H Rosenwasser; Pascal Jabbour Journal: Neurosurgery Date: 2022-05-01 Impact factor: 5.315